Drug delivery innovations push forth women’s health
From enhancing contraceptive methods to improving the treatment of reproductive health issues, drug delivery innovations are paving the way for…
04 Apr 2024
Harnessing pharmacovigilance to turn reactive investigation into active discovery
Pharmacovigilance uses science and action to detect, assess, understand and prevent adverse events (AEs) or other issues relating to medicines or vaccines. It is, therefore, a vital component in ensuring…
03 Apr 2024
Continuous monitoring expands aseptic knowledge and data in real time
Highlighted by the introduction of regulatory stipulation in August 2023, real-time monitoring for cleanrooms involves using particle counters and other devices to provide data on different parameters in a continuous…
02 Apr 2024
Can pharma overcome generative AI’s bias problem?
Generative artificial intelligence (AI) or gen AI refers to algorithms that can produce new content such as codes, text, images and simulations. Tools such as ChatGPT and chatbots provide an…
02 Apr 2024
Magazine: What’s next for AAV gene therapies in 2024?
As the number of specialised gene therapies continues to grow in the biotech sector, one particular subtype— those using adeno-associated virus (AAV) vectors—is becoming increasingly popular. In this month’s cover…
26 Mar 2024
The top emerging pharmaceutical companies in the US
While big pharma holds a sizable stake in the healthcare sector, several biotechs and mid-sized pharma companies fuel both the cutting-edge research and growing revenues in the pharmaceutical space. In…
21 Mar 2024
Molecular glues are the latest craze in pharma research, but what are they?
February’s announcement that Novo Nordisk was partnering with a biotech developing molecular glues to treat rare diseases was the latest in a series of expensive deals hoping to utilise the…